One clinical trial (NCT01677611) focused on the effects of resveratrol on skeletal muscle SIRT1 expression in adults with T2D (n = 10, 500 mg per day to 3 g per day in three divided doses for a total of 3 months). The gene discussed is SIRT1; the disease is type 2 diabetes mellitus.